Biotech investor, company builder

João brings together deep scientific expertise, business insight, and a strong entrepreneurial drive. He is currently a Principal at Novo Holdings, an interim executive at Booster Therapeutics, and serves on the boards of several biotech companies. In his current role, João led the investments in Tribune Therapeutics, Asgard Therapeutics, Orbis Medicines, and Booster Therapeutics.

Before joining Novo Holdings, João was part of the investment team at M Ventures, the corporate venture arm of Merck KGaA, where he was involved in transactions including Plexium and Pantheon Biosciences. Earlier in his career, he was a Fellow at the European Institute of Innovation and Technology and an active member of MIT Hacking Medicine. While in the US, João also served as President of a nonprofit organization.

He holds a Ph.D. in Bioengineering from the University of Coimbra, having conducted his doctoral thesis at Harvard Medical School & Brigham and Women's Hospital in Boston. He has received multiple awards for his entrepreneurial work.

Beyond the world of biotech and company building, João is a surfer, adventurer, and art enthusiast. He frequently paints and enjoys exploring the intersection between science and art as well as narrative painting.